Literature DB >> 1591679

Expression of transforming growth factor-alpha in gastric carcinoma and normal gastric mucosa cells.

W Müller1, F Borchard.   

Abstract

The presence of transforming growth factor-alpha (TGF-alpha) was studied in a total of 120 consecutive patients with gastric carcinomas. This immunohistochemical study found TGF-alpha expression in 60% (n = 72) of carcinomas. It also was detected in normal gastric epithelial mucosa in 36% (n = 43) of specimens. There was no significant statistical correlation between TGF-alpha expression and clinical features (e.g., patient age and sex) or pathologic features (e.g., tumor stage, grade, and localization or growth pattern according to an earlier histologic classification). Expression of TGF-alpha by these tumor cells had no influence on prognosis. It was neither a histopathologic marker of high malignancy nor a useful prognostic tool. It had no influence on the invasive growth pattern of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591679     DOI: 10.1002/1097-0142(19920615)69:12<2871::aid-cncr2820691202>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Preoperative staging of gastric cancer as precondition for multimodal treatment.

Authors:  A Sendler; H J Dittler; H Feussner; H Nekarda; E Bollschweiler; U Fink; H Helmberger; H Höfler; J R Siewert
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

Review 2.  Molecular biology and gastric carcinoma.

Authors:  P A Wright; G T Williams
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

3.  Developmental expression of transforming growth factor-alpha and epidermal growth factor receptor proteins in the human pancreas and digestive tract.

Authors:  K Hormi; T Lehy
Journal:  Cell Tissue Res       Date:  1994-12       Impact factor: 5.249

4.  Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.

Authors:  Julia Kneissl; Anja Hartmann; Nicole Pfarr; Franziska Erlmeier; Thomas Lorber; Simone Keller; Gwen Zwingenberger; Wilko Weichert; Birgit Luber
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-08       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.